Maximilian Merz
- Co-authors
- Tobias BäuerleWolfhard SemmlerDorde KomljenovicJens HillengaßHartmut GoldschmidtStefan ZwickMarc S. RaabAnna Jauch
- Topics
- Multiple Myeloma Research and Treatments (28 papers)CAR-T cell therapy research (12 papers)Protein Degradation and Inhibitors (10 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Maximilian Merz
50 papers receiving 658 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 360
- Hematology 324
- Oncology 246
- Radiology, Nuclear Medicine and Imaging 110
- Genetics 66
Countries citing papers authored by Maximilian Merz
This map shows the geographic impact of Maximilian Merz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Merz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Merz more than expected).
Fields of papers citing papers by Maximilian Merz
This network shows the impact of papers produced by Maximilian Merz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Merz. The network helps show where Maximilian Merz may publish in the future.
Co-authorship network of co-authors of Maximilian Merz
This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Merz. A scholar is included among the top collaborators of Maximilian Merz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Merz. Maximilian Merz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 12 | |
| 9 | 4 | |
| 10 | 11 | |
| 11 | 3 | |
| 12 | 2 | |
| 13 | 8 | |
| 14 | 20 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 18 | |
| 18 | 7 | |
| 19 | 6 | |
| 20 | 65 |
About Maximilian Merz
Maximilian Merz is a scholar working on Hematology, Oncology and Genetics, having authored 54 papers that have together received 670 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (28 papers), CAR-T cell therapy research (12 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Hematology (324 citations), Oncology (246 citations) and Genetics (66 citations). Maximilian Merz has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Tobias Bäuerle, Wolfhard Semmler, Dorde Komljenovic, Jens Hillengaß, Hartmut Goldschmidt, Stefan Zwick, Marc S. Raab, Anna Jauch, K. Martin Kortüm and Simon L. Goodman. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.